APTAHEM
Aptahem's development portfolio consists of aptamers , so-called synthetic (engineered) nucleic acid polymers. An aptamer consists of either single-stranded DNA or RNA (ssDNA or ssRNA). These molecules can bind specifically to already selected targets, including proteins and peptides with high affinity and specificity. Unlike antibodies, some aptamers exhibit stereoselectivity. Aptahem develops aptamer-based drugs for the treatment of life-threatening conditions where coagulation and inflammation interact in the disease process. Apta-1, the company's leading drug candidate, is an emergency medicine that is developed with the aim of stopping the organ and tissue damage that leads to the very high mortality rate for, among other things, sepsis patients.
APTAHEM
Industry:
Biotechnology
Founded:
2014-01-01
Address:
Malmö, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.aptahem.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Aptarion biotech
Aptarion biotech is a developer Biostable L-Aptamers for the treatment Of Life-Threatening diseases And for Biosensors.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-31 | Aptahem appoints CMC Director |
Official Site Inspections
http://www.aptahem.com
- Host name: webcluster2.webpod16-cph3.one.com
- IP address: 46.30.215.119
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
